Skip to main content

Oregon State Flag An official website of the State of Oregon »

Feedback forms

PDAB wants to hear from Oregonians about drug costs

TThe Oregon Prescription Drug Affordability Board (PDAB) is seeking input from patients, caregivers, and others about the cost of prescription medications. The board invites patients, caregivers, advocacy groups, medical professionals, manufacturers, safety net clinics, pharmacy benefit managers, and health plan insurers to submit a feedback form about the prescription drugs currently under board review: Jardiance, Mounjaro, Ozempic, Humulin R U-500, Keytruda, Verzenio, Xeljanz, Ocrevus, Skyrizi, Tremfya, and Xolair.. If any of these medications have affected your health, finances, or communities, please share your experiences with the board. Your feedback will help inform PDAB’s review process. Click on the link below to select the applicable form, complete the questions, and submit the form. Thank you in advance for your participation.

2026 FEEDBACK FORMS

  • PATIENTS, CAREGIVERS, AND ADVOCACY
  • For individuals who have been prescribed a medication on the review list, as well as their caregivers or family members. Advocacy groups representing patients or caregivers may also choose this form.
  • INDIVIDUALS WITH SCIENTIFIC OR MEDICAL TRAINING
  • For medical providers, doctors, nurses, professors, researchers, pharmacists, representatives of medical clinics and hospitals, and others with a background and training in medicine or science.
  • SAFETY NET PROVIDERS
  • For 340B clinics, federally qualified health centers serving Oregon communities, and coordinated care organizations serving Oregon Health Plan members.
  • MANUFACTURERS
  • For companies that manufacture prescription drugs and trade associations representing manufacturers.
  • PHARMACY BENEFIT MANAGERS
  • For pharmacy benefit managers – third-party administrators that manage prescription drug programs for health plans.
  • HEALTH PLAN INSURERS
  • For companies that provide health insurance to Oregonians.